Cargando…

Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification

The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessandrini, Francesca, Vennemann, Antje, Gschwendtner, Silvia, Neumann, Avidan U., Rothballer, Michael, Seher, Tanja, Wimmer, Maria, Kublik, Susanne, Traidl-Hoffmann, Claudia, Schloter, Michael, Wiemann, Martin, Schmidt-Weber, Carsten B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666465/
https://www.ncbi.nlm.nih.gov/pubmed/28961222
http://dx.doi.org/10.3390/nano7100300
_version_ 1783275319698915328
author Alessandrini, Francesca
Vennemann, Antje
Gschwendtner, Silvia
Neumann, Avidan U.
Rothballer, Michael
Seher, Tanja
Wimmer, Maria
Kublik, Susanne
Traidl-Hoffmann, Claudia
Schloter, Michael
Wiemann, Martin
Schmidt-Weber, Carsten B.
author_facet Alessandrini, Francesca
Vennemann, Antje
Gschwendtner, Silvia
Neumann, Avidan U.
Rothballer, Michael
Seher, Tanja
Wimmer, Maria
Kublik, Susanne
Traidl-Hoffmann, Claudia
Schloter, Michael
Wiemann, Martin
Schmidt-Weber, Carsten B.
author_sort Alessandrini, Francesca
collection PubMed
description The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supernatants from (5.6–45 µg/mL) Ag50-PVP, Ag200-PVP or Ag50-citrate-treated NR8383 alveolar macrophages were tested for lactate dehydrogenase and glucuronidase activity, tumor necrosis factor (TNF)-α release and reactive oxygen species (ROS) production. For the in vivo study, NPs were intratracheally instilled in non-sensitized (NS) and OVA-sensitized (S) mice (1–50 µg/mouse) prior to OVA-challenge and bronchoalveolar lavage fluid (BALF) inflammatory infiltrate was evaluated five days after challenge. In vitro results showed a dose-dependent cytotoxicity of Ag-NPs, which was highest for Ag50-polyvinilpyrrolidone (PVP), followed by Ag50-citrate, and lowest for Ag200-PVP. In vivo 10–50 µg Ag50-PVP triggered a dose-dependent pulmonary inflammatory milieu in NS and S mice, which was significantly higher in S mice and was dampened upon instillation of Ag200-PVP. Surprisingly, instillation of 1 µg Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in S mice and had no adverse effect in NS mice. Ag50-citrate showed similar beneficial effects at low concentrations and attenuated pro-inflammatory effects at high concentrations. The lung microbiome was altered by NPs instillation dependent on coating and/or mouse batch, showing the most pronounced effects upon instillation of 50 µg Ag50-citrate, which caused an increased abundance of operational taxonomic units assigned to Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. However, no correlation with the biphasic effect of low and high Ag-NPs dose was found. Altogether, both in vitro and in vivo data on the pulmonary effects of Ag-NPs suggest the critical role of the size, dose and surface functionalization of Ag-NPs, especially in susceptible allergic individuals. From the perspective of occupational health, care should be taken by the production of Ag-NPs-containing consumer products.
format Online
Article
Text
id pubmed-5666465
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56664652017-11-09 Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification Alessandrini, Francesca Vennemann, Antje Gschwendtner, Silvia Neumann, Avidan U. Rothballer, Michael Seher, Tanja Wimmer, Maria Kublik, Susanne Traidl-Hoffmann, Claudia Schloter, Michael Wiemann, Martin Schmidt-Weber, Carsten B. Nanomaterials (Basel) Article The growing use of silver nanoparticles (Ag-NPs) in consumer products raises concerns about their toxicological potential. The purpose of the study was to investigate the size- and coating-dependent pulmonary toxicity of Ag-NPs in vitro and in vivo, using an ovalbumin (OVA)-mouse allergy model. Supernatants from (5.6–45 µg/mL) Ag50-PVP, Ag200-PVP or Ag50-citrate-treated NR8383 alveolar macrophages were tested for lactate dehydrogenase and glucuronidase activity, tumor necrosis factor (TNF)-α release and reactive oxygen species (ROS) production. For the in vivo study, NPs were intratracheally instilled in non-sensitized (NS) and OVA-sensitized (S) mice (1–50 µg/mouse) prior to OVA-challenge and bronchoalveolar lavage fluid (BALF) inflammatory infiltrate was evaluated five days after challenge. In vitro results showed a dose-dependent cytotoxicity of Ag-NPs, which was highest for Ag50-polyvinilpyrrolidone (PVP), followed by Ag50-citrate, and lowest for Ag200-PVP. In vivo 10–50 µg Ag50-PVP triggered a dose-dependent pulmonary inflammatory milieu in NS and S mice, which was significantly higher in S mice and was dampened upon instillation of Ag200-PVP. Surprisingly, instillation of 1 µg Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in S mice and had no adverse effect in NS mice. Ag50-citrate showed similar beneficial effects at low concentrations and attenuated pro-inflammatory effects at high concentrations. The lung microbiome was altered by NPs instillation dependent on coating and/or mouse batch, showing the most pronounced effects upon instillation of 50 µg Ag50-citrate, which caused an increased abundance of operational taxonomic units assigned to Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria. However, no correlation with the biphasic effect of low and high Ag-NPs dose was found. Altogether, both in vitro and in vivo data on the pulmonary effects of Ag-NPs suggest the critical role of the size, dose and surface functionalization of Ag-NPs, especially in susceptible allergic individuals. From the perspective of occupational health, care should be taken by the production of Ag-NPs-containing consumer products. MDPI 2017-09-29 /pmc/articles/PMC5666465/ /pubmed/28961222 http://dx.doi.org/10.3390/nano7100300 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alessandrini, Francesca
Vennemann, Antje
Gschwendtner, Silvia
Neumann, Avidan U.
Rothballer, Michael
Seher, Tanja
Wimmer, Maria
Kublik, Susanne
Traidl-Hoffmann, Claudia
Schloter, Michael
Wiemann, Martin
Schmidt-Weber, Carsten B.
Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title_full Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title_fullStr Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title_full_unstemmed Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title_short Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface Modification
title_sort pro-inflammatory versus immunomodulatory effects of silver nanoparticles in the lung: the critical role of dose, size and surface modification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666465/
https://www.ncbi.nlm.nih.gov/pubmed/28961222
http://dx.doi.org/10.3390/nano7100300
work_keys_str_mv AT alessandrinifrancesca proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT vennemannantje proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT gschwendtnersilvia proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT neumannavidanu proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT rothballermichael proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT sehertanja proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT wimmermaria proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT kubliksusanne proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT traidlhoffmannclaudia proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT schlotermichael proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT wiemannmartin proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification
AT schmidtwebercarstenb proinflammatoryversusimmunomodulatoryeffectsofsilvernanoparticlesinthelungthecriticalroleofdosesizeandsurfacemodification